An Insulin for Fast, Effective Mealtime Control
Glossary
Rapid-acting Insulin
Insulin that starts to work quickly (usually within 15 minutes), with its peak activity (strongest effect) lasting only a few hours. Generally, rapid-acting insulin, like Humalog, is a mealtime insulin (except when used in an external insulin pump).
Insulin that starts to work quickly (usually within 15 minutes), with its peak activity (strongest effect) lasting only a few hours. Generally, rapid-acting insulin, like Humalog, is a mealtime insulin (except when used in an external insulin pump).
Convenience in dosing
With Humalog, you can enjoy "dose-and-eat" convenience. Humalog can be taken within 15 minutes before or immediately after a meal. Its dosing schedule is flexible because your insulin dose doesn't determine when you eat — you do. This means you can better manage your diabetes even when you run into unexpected delays or schedule changes. Humalog is also approved for use in insulin pumps, in which case tiny doses of Humalog are delivered throughout the day to help keep your blood sugar stable. (More on insulin pumps...)
The convenience of mealtime controlHumalog is available in a variety of prefilled and reusable insulin pens. These Pens can be used just about anywhere — at work, in restaurants, or at a picnic. Before use, patients are advised to carefully read the User Manual provided with each Pen and the Patient Information provided with the Pen or Humalog insulin cartridges.
Humalog is available by prescription only. See Humalog Patient Information for important facts about this product.
HumaPen MEMOIR and HumaPen LUXURA HD are available by prescription only.
Humalog insulins start lowering blood sugar more quickly than regular human insulin, allowing for convenient dosing immediately before a meal (within 15 minutes). Humalog can even be taken immediately after your meal. Because Humalog is a mealtime insulin, you may also need a longer-acting insulin to get the best blood sugar control (except when using an insulin pump).
Important Safety Information
Humalog, Humalog Mix75/25, and Humalog Mix50/50 are for use in patients with diabetes to control high blood sugar. Humalog should be used with a longer-acting insulin, except when used in combination with sulfonylureas in patients with type 2 diabetes.
Humalog insulins are contraindicated during episodes of hypoglycemia and in patients sensitive to Humalog or one of its excipients. The safety and effectiveness of Humalog in patients less than 3 years of age have not been established. Safety and effectiveness of Humalog Mix75/25 and Humalog Mix50/50 in patients less than 18 years of age have not been established. There are no clinical studies of the use of Humalog insulins in pregnancy or nursing mothers.
Potential side effects associated with the use of all insulins include low blood sugar, weight gain, low blood potassium, changes in fat tissue at the site of injection, and allergic reactions, both general and local. Humalog Mix75/25 and Humalog Mix50/50 should not be mixed with another insulin. Starting or changing insulin therapy should be done cautiously and only under medical supervision.
Humalog insulins are available by prescription only. See the Humalog, Humalog Mix75/25, and Humalog Mix50/50 Patient Product Information for important facts about these products.
Humalog is a registered trademark of Eli Lilly and Company. Humalog Mix75/25 and Humalog Mix50/50 are trademarks of Eli Lilly and Company.
Humalog, Humalog Mix75/25, and Humalog Mix50/50 are for use in patients with diabetes to control high blood sugar. Humalog should be used with a longer-acting insulin, except when used in combination with sulfonylureas in patients with type 2 diabetes.
Humalog insulins are contraindicated during episodes of hypoglycemia and in patients sensitive to Humalog or one of its excipients. The safety and effectiveness of Humalog in patients less than 3 years of age have not been established. Safety and effectiveness of Humalog Mix75/25 and Humalog Mix50/50 in patients less than 18 years of age have not been established. There are no clinical studies of the use of Humalog insulins in pregnancy or nursing mothers.
Potential side effects associated with the use of all insulins include low blood sugar, weight gain, low blood potassium, changes in fat tissue at the site of injection, and allergic reactions, both general and local. Humalog Mix75/25 and Humalog Mix50/50 should not be mixed with another insulin. Starting or changing insulin therapy should be done cautiously and only under medical supervision.
Humalog insulins are available by prescription only. See the Humalog, Humalog Mix75/25, and Humalog Mix50/50 Patient Product Information for important facts about these products.
Humalog is a registered trademark of Eli Lilly and Company. Humalog Mix75/25 and Humalog Mix50/50 are trademarks of Eli Lilly and Company.
